Icade Past Earnings Performance

Past criteria checks 0/6

Icade's earnings have been declining at an average annual rate of -58.7%, while the REITs industry saw earnings growing at 14.3% annually. Revenues have been declining at an average rate of 0.3% per year.

Key information

-58.7%

Earnings growth rate

-58.5%

EPS growth rate

REITs Industry Growth	12.6%
Revenue growth rate	-0.3%
Return on equity	-26.2%
Net Margin	-84.5%
Next Earnings Update	22 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Icade makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ENXTPA:ICAD Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	1,525	-1,289	367
30 Sep 23	1,494	-1,116	370
30 Jun 23	1,825	-519	426
31 Mar 23	1,827	-232	421
31 Dec 22	1,469	-370	361
30 Sep 22	1,496	-61	415
30 Jun 22	1,524	249	468
31 Mar 22	1,586	324	425
31 Dec 21	1,648	399	382
30 Jun 21	1,640	280	228
31 Mar 21	1,534	178	225
31 Dec 20	1,429	76	222
30 Jun 20	1,458	259	224
31 Mar 20	1,485	278	221
31 Dec 19	1,512	298	218
30 Sep 19	1,587	235	215
30 Jun 19	1,662	173	212
31 Mar 19	1,717	165	220
31 Dec 18	1,773	156	229
30 Sep 18	1,714	137	229
30 Jun 18	1,655	118	230
31 Mar 18	1,642	142	227
31 Dec 17	1,629	165	224
30 Jun 17	1,596	106	219
31 Mar 17	1,542	75	212
31 Dec 16	1,487	45	205
30 Jun 16	1,391	-101	204
31 Mar 16	1,411	-144	205
31 Dec 15	1,431	-187	206
30 Jun 15	1,649	82	194
31 Mar 15	1,687	116	212
31 Dec 14	1,725	151	229
30 Sep 14	1,683	111	273
30 Jun 14	1,602	79	266
31 Mar 14	1,540	103	252
31 Dec 13	1,479	127	238
30 Sep 13	1,467	71	245
30 Jun 13	1,456	15	253

Quality Earnings: ICAD is currently unprofitable.

Growing Profit Margin: ICAD is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ICAD is unprofitable, and losses have increased over the past 5 years at a rate of 58.7% per year.

Accelerating Growth: Unable to compare ICAD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ICAD is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (-15.3%).

Return on Equity

High ROE: ICAD has a negative Return on Equity (-26.22%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Icade Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Recent updates

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Dividend of €2.42 announced

Now 21% undervalued after recent price drop

Upcoming dividend of €2.42 per share

Icade, Annual General Meeting, Apr 19, 2024

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Consensus EPS estimates fall by 63%

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade(ENXTPA:ICAD) dropped from FTSE All-World Index (USD)

Price target decreased by 7.3% to €41.55

Consensus EPS estimates fall by 160%

Now 20% undervalued after recent price drop

Primonial REIM and Société Générale Assurances completed the acquisition of 63% stake in Icade Santé SAS from Icade (ENXTPA:ICAD) and its Minority Shareholders.

Upcoming dividend of €2.17 per share at 12% yield

Consensus estimates of losses per share improve by 75%

Vauban Infrastructure Partners and Icade (ENXTPA:ICAD) agreed to acquire A2A Coriance SAS.

Consensus EPS estimates fall by 17%, revenue upgraded

Oteis France Sas agreed to acquire AMO and EXPERTISE SANTE activity from Icade (ENXTPA:ICAD).

Consensus EPS estimates fall by 17%

Consensus estimates of losses per share improve by 16%

Consensus EPS estimates fall by 15%

An undisclosed buyer acquired Michigan Garden Project from Icade SA (ENXTPA:ICAD) for €108 million.

Icade SA (ENXTPA:ICAD) acquired Défense Parc complex in Nanterre Préfecture for €63 million.

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Consensus forecasts updated

Consensus forecasts updated

Elysées Pierre signed a bilateral preliminary agreement to acquire 16,000-Sq.m AXE 13 Office Building in Nanterre from Icade (ENXTPA:ICAD).

Investor sentiment deteriorated over the past week

Upcoming dividend of €2.10 per share

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Residences Le Logement Des Fonctionnaires SA signed a bilateral preliminary agreement to acquire Residual Residential Portfolio from Icade (ENXTPA:ICAD) for €49.9 million.

Icade (ENXTPA:ICAD) acquired 50.1% interest in M&A Group.

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

An unknown buyer completed the acquisition of Office building in Boulogne-Billancourt from Icade SA (ENXTPA:ICAD).

Consensus EPS estimates increase to €1.91

Consensus EPS estimates increase to €1.10

First half 2021 earnings released: EPS €2.52 (vs €0.07 in 1H 2020)

Consensus forecasts updated

Revenue beats expectations, earnings disappoint

A Look At Icade's (EPA:ICAD) Share Price Returns

New 90-day low: €55.50

Analysts update estimates

How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

A pan-European fund dedicated to a German institutional investor managed by Aberdeen Standard Investments Limited acquired Two residential buildings in Rueil-Malmaison from Icade SA (ENXTPA:ICAD) for €14.6 million.

Icade SA (ENXTPA:ICAD) acquired Ad Vitam

Icade SA to Report Q1, 2021 Results on Apr 23, 2021

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

New 90-day high: €68.20

Market bids up stock over the past week

New 90-day low: €42.96

New 90-day low: €48.00

Analysts lower EPS estimates to €1.11

New 90-day low - €54.25

OPPCI owned by South Korean Investors completed the acquisition of 49% stake in Eqho Tower from Icade (ENXTPA:ICAD).

Icade (ENXTPA:ICAD) completed the acquisition of Pointe Métro 1 in Gennevilliers from Fonciere NW 2 Sppicav managed by NORMANDIE REIM.

New 90-day low - €55.45

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Revenue & Expenses Breakdown
Beta